deltatrials
Active Not Recruiting PHASE2 INTERVENTIONAL 2-arm NCT01686334

Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission (WIDEA)

Wilms' Tumor (WT1) Antigen-targeted Dendritic Cell Vaccination to Prevent Relapse in Adult Patients With Acute Myeloid Leukemia: a Multicenter Randomized Phase II Trial

Sponsor: Kom Op Tegen Kanker

Conditions Acute Myeloid Leukemia
Interventions DC vaccine
Updated 14 times since 2017 Last updated: Mar 8, 2024 Started: Oct 31, 2012 Primary completion: Dec 31, 2025 Completion: Dec 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Acute Myeloid Leukemia, this trial is ongoing. The trial is conducted by Kom Op Tegen Kanker and has accumulated 14 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Jul 2017 · 6 months · monthly snapshot~Jul 2017 – ~Dec 2017 · 5 months · monthly snapshot~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Nov 2019 · 17 months · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2021 · 13 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Oct 2021 · 8 months · monthly snapshot~Oct 2021 – ~Dec 2023 · 26 months · monthly snapshot~Dec 2023 – ~Apr 2024 · 4 months · monthly snapshot~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2025 — Present [monthly]

    Active Not Recruiting PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Active Not Recruiting PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

  4. Apr 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  5. Dec 2023 — Apr 2024 [monthly]

    Recruiting PHASE2

▶ Show 9 earlier versions

  1. Oct 2021 — Dec 2023 [monthly]

    Recruiting PHASE2

  2. Feb 2021 — Oct 2021 [monthly]

    Recruiting PHASE2

  3. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE2

  4. Dec 2019 — Jan 2021 [monthly]

    Recruiting PHASE2

  5. Nov 2019 — Dec 2019 [monthly]

    Recruiting PHASE2

  6. Jun 2018 — Nov 2019 [monthly]

    Recruiting PHASE2

  7. Dec 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  8. Jul 2017 — Dec 2017 [monthly]

    Recruiting PHASE2

  9. Jan 2017 — Jul 2017 [monthly]

    Recruiting PHASE2

    First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Kom Op Tegen Kanker
  • Research Foundation Flanders
  • Stichting tegen Kanker
  • Zwi Berneman
Data source: University Hospital, Antwerp

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations